AbbVie (ABBV) Change in Inventory (2012 - 2026)

AbbVie (ABBV) has 15 years of Change in Inventory data on file, last reported at $184.0 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $184.0 million, up 18.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $263.0 million (down 34.09% YoY), and the FY2025 annual result was $234.0 million, down 26.65% from the prior year.
• Change in Inventory advanced to $184.0 million in Q1 2026 per ABBV's latest filing, from $25.0 million in the prior quarter.
• Over five years, Change in Inventory peaked at $385.0 million in Q1 2022 and troughed at -$96.0 million in Q4 2023.
• A 5-year average of $108.2 million and a median of $75.0 million in 2024 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2024: Change in Inventory slumped 156.47% in 2023, then surged 233.33% in 2024.
• A 5-year view of Change in Inventory shows it stood at $170.0 million in 2022, then sank by 156.47% to -$96.0 million in 2023, then surged by 233.33% to $128.0 million in 2024, then plunged by 80.47% to $25.0 million in 2025, then surged by 636.0% to $184.0 million in 2026.
• Business Quant data shows ABBV's Change in Inventory at $184.0 million in Q1 2026, $25.0 million in Q4 2025, and -$2.0 million in Q3 2025.